Company

Lilly

Official Name: Eli Lilly and Company

Headquarters: Indianapolis, IN, United States

Founded: 1876

Employees: 35,000

CEO: Mr. David A. Ricks

NYSE: LLY +1.01%

Market Cap

$808.65 Billion

USD as of July 1, 2024

Market Cap History

Company Description

Eli Lilly and Company, more simply known as Eli Lilly or just Lilly, is a pharmaceutical company. Founded in 1876, Eli Lilly is engaged in the research, development, manufacturing, and marketing of insulin and endocrinology products for diabetes, psychiatric medication including Prozac, as well as treatments for osteoporosis, human growth hormone deficiency, pediatric growth conditions, autoimmune diseases, and diverse types of cancers.

Lilly market capitalization over time

Evolution of Eli Lilly and Company market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Eli Lilly and Company

Detailed Description

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Top 1-year algo backtest: +207.50%

$10,000 in July 2023 would now be $30,750 by following this algorithm daily at market close.

Boost your returns with Disfold DeepFinance... Now!

Try Disfold DeepFinance FREE

Stocks & Indices

Eli Lilly and Company has the following listings and related stock indices.


Stock: NYSE: LLY wb_incandescent

Stock: FSX: LLY wb_incandescent

Stock: XETR: LLY wb_incandescent

Product & Services

Pharmaceutical drugs

Key People

Founder(s): Eli Lilly

David A. Ricks (Chairperson, President, & CEO) Anat Ashkenazi (Vice president & CFO)

Financials

Revenue: US$22.319 billion (2019)

Operating income: US$5.595 billion (2019)

Net income: US$8.318 billion (2019)


Total assets: US$39.286 billion (2019)

Total equity: US$2.699 billion (2019)

Details

Headquarters:

Lilly Corporate Center

Indianapolis, IN 46285

United States

Phone: 317 276 2000